SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

It's important to know the cause of your cirrhosis so you can get the right treatment and keep it from getting worse. The most common causes are: Alcohol use disorder. If you have a drinking ...

Liver cirrhosis is a progressive disease that affects millions worldwide, leading to severe complications such as hepatic ...

(NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced a significant ...

At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...

Rising rates of metabolic dysfunction–associated steatohepatitis indicate a need for public health interventions.

Michelle Tratchenberg, 39, had received a liver transplant in the months leading up to her death. While a cause of death has ...

There has been a tremendous rise in the number of deaths in Goa due to alcohol-related liver cirrhosis in youngsters, ...

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as ...

Still, experts expressed optimism about the study’s implications, particularly if weight loss from new medications proved to have a similar effect on cirrhosis. In the last several months ...